title: [HEPATIC ENCEPHALOPATHY AND TISSUE ZINC LEVELS IN LIVER DISEASE, DIAGNOSIS AND TREATMENT].
abstract: THE PURPOSE OF THE REVIEW: Description One of the complications of liver disease--hepatic encephalopathy as well as its relationship with the content of zinc in the body. THE MAIN PROVISIONS: The review provides the key moments of the pathophysiology and clinical hepatic encephalopathy. The basic drugs and treatment regimens of hepatic encephalopathy. Data are considered the original author's research on the relationship of gravity of hepatic encephalopathy and tissue zinc levels in patients with hepatitis and cirrhosis of viral etiology. The data of modern meta-analyzes of complex treatment of hepatic encephalopathy and the role of L-ornithine-L-aspartate.
  
  
  CONCLUSIONS
  Understanding the pharmacological mechanisms of action of L-ornithine-L-aspartate allow gastroenterologist physicians and general practitioners to adequately apply the drug, select the required readings and prioritize the treatment of patients with liver diseases at different stages of the disease. Should be included in the treatment regimen of hepatic encephalopathy zinc supplements.
authors.forename: E Y
authors.initials: EY
authors.lastname: Plotnikova
authors.forename: E N
authors.initials: EN
authors.lastname: Baranova
authors.forename: S A
authors.initials: SA
authors.lastname: Maksimov
mesh_terms: D004151:Dipeptides / Q000627:therapeutic use*; D006501:Hepatic Encephalopathy / Q000175:diagnosis* / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D015032:Zinc / Q000378:metabolism*
chemical_list: D004151:Dipeptides; D015032:Zinc; C002939:ornithylaspartate